Ovarian Colorado
Information for the Public
References:
ACOG Committee Opinion #280,The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. December, 2002
American Medical Association. Identifying and managing hereditary risk for breast and ovarian cancer. Chicago, 2001
Brose, MS et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. JNCI 94:1365-72, 2002
Brown JK et al. Nutrition and physical activity during and after cancer treatment: An American cancer society guide for informed choices. CA Cancer J Clin 53:268-291, 2003.
Daly MB, Ozols RF. Symptoms of ovarian cancer: Where to set the bar? JAMA, 291(22):2755-56, 2004 June 9.
Goff BA et al. Ovarian cancer: Patterns of surgical care across the United States. Gynecol Oncol 103(2):383-90, 2006 Nov.
Goff BA et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer, 2006 Dec 11.
Goff BA, Mandel LS, Melancon CH, & Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA, 291(22): 2705-11, 2004 June 9.
Goff, BA, et al. Ovarian carcinoma diagnosis. Cancer 89:2068-75, 2000
Kauff, ND et al. Risk-reducing salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. NEJM 346:1609-15, 2002
Pal T et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer, 104(12):2807-16, 2005 Dec 15.
Rebbeck, TR et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. NEJM 346:1616-1622, 2002.
Seaward BL. (2004). Managing stress: Principles and strategies for health and well-being. (4th edition). Boston: Jones and Bartlett Publishers.
Thompson, D et al. Cancer incidence in BRCA1 mutation carriers. JNCI 94:1358-65, 2002